The Suez Canal University is an Egyptian university serving the Suez Canal region. Its faculties are located in the three governorates of the Suez Canal Region. It was established in 1974. It is well-known for its non-traditional research. It has 48 faculties with a total number of students reaching 21,325.

During the past decade, Suez canal University conducted 34 clinical trials. In the 10-year time frame, 34 clinical trials started and 1 clinical trials were completed, i.e. on average, 2.9% percent of trials that started reached the finish line to date. In the past 5 years, 22 clinical trials started and 1 clinical trials were completed. i.e. 4.5% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Suez canal University" #1 sponsor was "Suez Canal University" with 31 trials, followed by "Daiichi Sankyo, Inc." with 1 trials sponsored, "Egyptian Russian University" with 1 trials sponsored, "European Egyptian Pharmaceutical Industries" with 1 trials sponsored and "Population Health Research Institute" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Suez canal University" #1 collaborator was "Alexandria University" with 1 trials as a collaborator, "Bayer" with 1 trials as a collaborator, "National Research Centre, Egypt" with 1 trials as a collaborator and "University of Cape Town" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "Suez canal University" are "Dental Fluorosis" (2 trials), "Drug Effect" (2 trials), "Abnormality of Mitral Valve Annulus (Disorder)" (1 trials), "Adrenal Disease" (1 trials) and "Adrenal Mass" (1 trials). Many other conditions were trialed in "Suez canal University" in a lesser frequency.

Most popular intervention types in "Suez canal University" are "Drug" (14 trials), "Procedure" (12 trials), "Device" (9 trials), "Other" (2 trials) and "Behavioral" (1 trials). Other intervention types were less common.

The name of intervention was led by "Dexmedetomidine" (2 trials), "MI-Paste Plus®" (2 trials), "Opalescence™ boost™ PF 40%" (2 trials), "Opalustre™" (2 trials) and "After the education program" (1 trials). Other intervention names were less common.

The vast majority of trials in "Suez canal University" are 29 trials for "All" genders, 5 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Suez canal University". undefined are not yet recruiting, 2 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 29 completed trials in Suez canal University, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Suez canal University, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 27 trials that are defined as “Not Applicable".

Suez canal University has several departments that took part in Clinical trials: "Faculty of Medicine, Suez Canal University" - 2 trials